Causal Association Between Periodontitis and Hypertension: Evidence from Mendelian Randomization and a Randomized Controlled Trial of Non-surgical Periodontal Therapy
Overview
Authors
Affiliations
Aims: Inflammation is an important driver of hypertension. Periodontitis is a chronic inflammatory disease, which could provide a mechanism for pro-hypertensive immune activation, but evidence of a causal relationship in humans is scarce. We aimed to investigate the nature of the association between periodontitis and hypertension.
Methods And Results: We performed a two-sample Mendelian randomization analysis in the ∼750 000 UK-Biobank/International Consortium of Blood Pressure-Genome-Wide Association Studies participants using single nucleotide polymorphisms (SNPs) in SIGLEC5, DEFA1A3, MTND1P5, and LOC107984137 loci GWAS-linked to periodontitis, to ascertain their effect on blood pressure (BP) estimates. This demonstrated a significant relationship between periodontitis-linked SNPs and BP phenotypes. We then performed a randomized intervention trial on the effects of treatment of periodontitis on BP. One hundred and one hypertensive patients with moderate/severe periodontitis were randomized to intensive periodontal treatment (IPT; sub- and supragingival scaling/chlorhexidine; n = 50) or control periodontal treatment (CPT; supragingival scaling; n = 51) with mean ambulatory 24-h (ABPM) systolic BP (SBP) as primary outcome. Intensive periodontal treatment improved periodontal status at 2 months, compared to CPT. This was accompanied by a substantial reduction in mean SBP in IPT compared to the CPT (mean difference of -11.1 mmHg; 95% CI 6.5-15.8; P < 0.001). Systolic BP reduction was correlated to periodontal status improvement. Diastolic BP and endothelial function (flow-mediated dilatation) were also improved by IPT. These cardiovascular changes were accompanied by reductions in circulating IFN-γ and IL-6 as well as activated (CD38+) and immunosenescent (CD57+CD28null) CD8+T cells, previously implicated in hypertension.
Conclusion: A causal relationship between periodontitis and BP was observed providing proof of concept for development of clinical trial in a large cohort of hypertensive patients. ClinicalTrials.gov: NCT02131922.
Arregoces F, Roa N, Velosa-Porras J, Rodriguez L, Merchan M, Poveda J Biomedicines. 2025; 13(2).
PMID: 40002786 PMC: 11853083. DOI: 10.3390/biomedicines13020374.
Yang H, Qin Y, Geng J, Qu J, Cheng Q, Li K BMC Oral Health. 2025; 25(1):273.
PMID: 39984899 PMC: 11843814. DOI: 10.1186/s12903-025-05665-4.
Chen J BMC Public Health. 2025; 25(1):455.
PMID: 39905341 PMC: 11796195. DOI: 10.1186/s12889-025-21658-y.
Connection between oral health and chronic diseases.
Fu D, Shu X, Zhou G, Ji M, Liao G, Zou L MedComm (2020). 2025; 6(1):e70052.
PMID: 39811802 PMC: 11731113. DOI: 10.1002/mco2.70052.
Czarnowski M, Wnorowska U, Luckiewicz M, Dargiewicz E, Spalek J, Okla S Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770567 PMC: 11678171. DOI: 10.3390/ph17121725.